RVL Pharmaceuticals share price logo

RVL Pharmaceuticals

OTC: RVLPQ

Live

as on

RVL Pharmaceuticals Stock Performance

as on October 24, 2026 at 3:56 am IST

RVL Pharmaceuticals share price movements today

Previous Close
-
Open
-
Volume
100.0
Market Cap
$1.1K

RVL Pharmaceuticals Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
-99.97 %
5 Year Return
0 %

RVL Pharmaceuticals Stock Fundamentals & Key Indicators

Check RVL Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1K

EPS (TTM)

-0.7

Dividend Yield

0.00%

PE Ratio (TTM)

-0.05

Industry PE ratio

-3.98

PEG Ratio

0.04

Return On Equity TTM

-80.88%

RVL Pharmaceuticals stock Key Stats

Compare market cap, revenue, PE, and other key metrics of RVL Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
RVL Pharmaceuticals image
RVL Pharmaceuticals
NA$1.1KNA-0.0580.98%0.00%

Stock Returns calculator for RVL Pharmaceuticals Stock including INR - Dollar returns

The RVL Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 3Y

RVL Pharmaceuticals investment value today

Current value as on today

Returns

(0%)

Returns from RVL Pharmaceuticals Stock

(0%)

Dollar Impact

(0%)

Indian Investors' Interest in RVL Pharmaceuticals Stock

Search interest for RVL Pharmaceuticals Stock has increased by 450% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:450% versus previous 30 day period

RVL Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Total Revenue
23
11
2
2
21
8
10
9
8
8
Gross Profit
10
10
1
1
19
6
7
7
6
6
Operating Income
-6
-20
-25
-23
-5
-15
-13
-11
-10
-22
EBITDA
-2
-21
-17
-15
-5
-11
-18
-16
-4
0
Interest Expense
2
0
0
2
2
0
-3
1
7
3
Depreciation
3
-3
7
0
0
0
0
0
0
0
Income Before Tax
-9
-21
-17
-19
-6
-11
-14
-18
-11
-24
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-9
-17
-17
-19
-6
-12
-14
-18
-11
-23
Net Profit Margin
43.51%
93.84%
-292.76%
58.85%
89.65%
72.73%
74.00%
73.90%
73.97%
76.43%

RVL Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Total Revenue
245
263
240
27
17
49
Gross Profit
120
123
128
24
13
40
Operating Income
-52
-98
3
-61
-80
-45
EBITDA
62
-664
-49
-69
-70
-48
Interest Expense
29
20
18
4
4
3
Depreciation
46
81
57
21
8
0
Income Before Tax
-85
-118
-298
-94
-82
-51
Income Tax Expense
-40
-8
-27
-5
0
0
Net Income
-45
-109
-270
-89
-82
-51
Net Profit Margin
48.61%
46.17%
53.49%
88.14%
79.33%
80.98%

RVL Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Net Income
-9
-17
-17
-19
-6
-12
-14
-18
-11
-23
Operating Cash Flow
-11
-2
-15
-24
-13
1
-10
-16
-5
-12
Investing Cash Flow
6
0
110
0
0
0
0
0
-1
0
Financing Cash Flow
0
-5
-186
56
0
0
42
1
-4
0
Change in Cash
-4
-9
-91
32
-14
1
32
-15
-11
-13

RVL Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Net Income
-45
-109
-270
-79
-64
-51
Operating Cash Flow
57
37
33
17
-54
-37
Investing Cash Flow
-19
-4
-4
-3
116
0
Financing Cash Flow
-23
3
-4
3
-135
41
Change in Cash
15
36
25
18
-73
4

About RVL Pharmaceuticals

RVL Pharmaceuticals plc operates as a specialized drug company, dedicated to innovating and marketing pharmaceutical solutions for patient groups with unmet needs in the ophthalmic and medical aesthetics domains. The firm's activities extend across the United States, Argentina, and Hungary. Its principal commercial offering is Upneeq (RVL-1201), an ophthalmic solution containing oxymetazoline hydrochloride, specifically formulated to address acquired blepharoptosis, or drooping eyelids, in adults. The company, formerly known as Osmotica Pharmaceuticals plc, officially rebranded to RVL Pharmaceuticals plc in January 2022. Its corporate headquarters are situated in Bridgewater, New Jersey.
OrganisationRVL Pharmaceuticals
Headquarters400 Crossing Boulevard, Bridgewater, NJ, 08807, US
IndustryBiotechnology
CEOBrian A. Markison

Key Management of RVL Pharmaceuticals

Name

Title

Mr. Brian A. Markison

President & Principal Financial Officer

Mr. James D. Schaub

Executive VP & COO

FAQs

What is RVL Pharmaceuticals's market capitalisation today?

RVL Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in RVL Pharmaceuticals Stock (RVLPQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for RVL Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy RVL Pharmaceuticals Stock (RVLPQ) from India?

Indian investors can start investing in RVL Pharmaceuticals (RVLPQ) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in RVL Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .